Granulocyte–macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

Publication | Closed Access

DOI

Citations

References

1999

Year

Xavier Thomas, Pierre Fenaux, Hervé Dombret, Sylvie Delair, François Dreyfus, Hervé Tilly, Anne Vekhoff, Pascale Cony‐Makhoul, V. Leblond, Xavier Troussard,

Leukemia

Hematological MalignancyEma91 TrialMedicineAcute Myeloid LeukemiaImmunologyTumor ImmunityClinical TrialsHematologyMyeloid NeoplasiaIntensive Sequential ChemotherapyOncologyCancer ResearchHealth Sciences